ENSYSCE BIOSCIENCES, INC.: 10-Q filed 2019-11-07
What ENSYSCE BIOSCIENCES, INC. reported in its quarterly report filed 2019-11-07 (fiscal Q3 2019): 19 published measures, 56 facts as tagged in accession 0001213900-19-022353.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-11-07
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001213900-19-022353 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ENSYSCE BIOSCIENCES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 207,210,734 | USD | |
| At 2018-12-31 | 204,831,755 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 8,134,091 | USD | |
| At 2018-12-31 | 7,439,650 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 5,000,001 | USD | |
| At 2019-06-30 | 5,000,001 | USD | |
| At 2019-03-31 | 5,000,001 | USD | |
| At 2018-12-31 | 5,000,001 | USD | |
| At 2018-06-30 | 5,000,001 | USD | |
| At 2018-03-31 | 5,000,001 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 489,723 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 1,684,538 | USD | 273 |
| 2019-04-01 to 2019-06-30 | 418,902 | USD | 91 |
| 2019-01-01 to 2019-03-31 | 775,913 | USD | 90 |
| 2018-07-01 to 2018-09-30 | 577,649 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 1,398,825 | USD | 273 |
| 2018-04-01 to 2018-06-30 | 415,110 | USD | 91 |
| 2018-01-01 to 2018-03-31 | 406,066 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -999,036 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -779,622 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -8,640 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -32,000 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 623,204 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 475,814 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 3,775,378 | USD | |
| At 2018-12-31 | 2,090,840 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 14,318 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 455,888 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 130,125 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 373,026 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -584,418 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -1,399,530 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -248,187 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -729,859 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 1,378,243 | USD | |
| At 2018-12-31 | 1,916,016 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 1,125,171 | USD | |
| At 2018-12-31 | 437,886 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 1,125,171 | USD | |
| At 2018-12-31 | 429,246 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 584,418 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 1,399,530 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 848,192 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 1,329,864 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 6,139,524 | shares | |
| At 2018-12-31 | 6,039,072 | shares |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 8,640 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 504,041 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 2,140,426 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 707,774 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 1,771,851 | USD | 273 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -476,042 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -1,082,288 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -293,159 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -866,854 | USD | 273 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 7,156 | USD | 273 |
Inspect the source
- Entity
- ENSYSCE BIOSCIENCES, INC. / CIK 0001716947
- Captured
- 2026-09-21T17:24:39.335Z
- SEC response SHA-256
28573a09f81da1511239531464c03b2552a3554a684a233653f365b194b6ca0b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001716947.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))